eyenovia-logo 3

SEC Filings

SEC Filings

Filing date Form Description Filing Group View
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
EX-101.INS - XBRL INSTANCE DOCUMENT
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
EX-101.INS - XBRL INSTANCE DOCUMENT
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
EX-101.INS - XBRL INSTANCE DOCUMENT
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
EX-101.INS - XBRL INSTANCE DOCUMENT
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
3

Initial filing by director officer or owner of more than ten percent.

3,4,5

Contact us for more information

Contact us today to learn more about how our microdosing technology is poised to transform
the standard of care in ophthalmic therapeutic delivery.

295 Madison Ave., Suite 2400, New York, NY 10017     +1 (917) 289-1117

[email protected]